FIELD: medicine.
SUBSTANCE: invention relates to a peptidyl analogue representing (Aib2, Glu3(NH-hexyl))ghrelin(1-28)-NH2 displaying agonistic activity with respect to ghrelin receptor.
EFFECT: invention can be used for treatment or prevention or decrease in probability or severity of disease or condition accompanied by weight loss.
8 cl, 1 tbl, 6 ex
Authors
Dates
2009-11-20—Published
2003-07-23—Filed